BioNTech Stock News & Updates
[WKN: A2PSR2 | Symbol: BNTX]
BioNTech: Vaccine Decline Meets Promising Lung Cancer Approach
BioNTech is forcing the transition from a vaccine manufacturer to a diversified oncology company. ...
BioNTech: Entering the Future of Oncology with Strong Data and Full Coffers
Current market situation After successes in infectious diseases, BioNTech (BNTX) is now fully focused...
BioNTech: Founders Announce Withdrawal and Stock Plummets 18% in Pre-Market!
BioNTech SE (NASDAQ: BNTX) reported revenues of €2.9 billion for the fiscal year 2025, slightly more...
Analysts' Top 5 Price Targets of January 16, 2025
Fair Isaac [US3032501047] Jefferies confirms Buy rating and adjusts the price target from $2100 to...
Biontech: CureVac Acquisition Sharpens mRNA Strategy!
Biontech has completed the acquisition of the Tübingen biotech company CureVac, marking a significant...
- ‹
- 1
- ›